These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8296795

  • 21. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.
    Lasky LC, Warkentin PI, Kersey JH, Ramsay NK, McGlave PB, McCullough J.
    Transfusion; 1983; 23(4):277-85. PubMed ID: 6410549
    [Abstract] [Full Text] [Related]

  • 22. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice.
    Tomita H, Fuchimoto Y, Mori T, Kato J, Uemura T, Handa M, Tazawa H, Ohdan H, Okamoto S, Kuroda T.
    Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194
    [Abstract] [Full Text] [Related]

  • 23. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G, Muntwyler J, Passweg JR, Seebach L, Schanz U, Gmür J, Gratwohl A, Seebach JD.
    Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [ABO-incompatible allogeneic bone marrow transplantation].
    Xu L, Guo N, Wang S.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Administration of haptoglobin in ABO incompatible bone marrow transplantation].
    Ito M, Imoto S, Nakagawa T, Kai S, Hara H.
    Rinsho Ketsueki; 1990 Oct; 31(10):1716-20. PubMed ID: 2255063
    [Abstract] [Full Text] [Related]

  • 29. [Isoagglutinins after bone marrow transplantation with minor ABO incompatibility].
    Wernet D, Mayer G.
    Beitr Infusionsther; 1992 Oct; 30():359-62. PubMed ID: 1284734
    [Abstract] [Full Text] [Related]

  • 30. Recombinant human erythropoietin for long-term persistent anemia after major ABO-incompatible bone marrow transplantation.
    Taniguchi S, Yamasaki K, Shibuya T, Asayama R, Harada M, Niho Y.
    Bone Marrow Transplant; 1993 Oct; 12(4):423. PubMed ID: 8275046
    [No Abstract] [Full Text] [Related]

  • 31. A study of the effect of ABO incompatible plasma in platelet concentrates transfused to bone marrow transplant recipients.
    Shanwell A, Ringdén O, Wiechel B, Rumin S, Akerblom O.
    Vox Sang; 1991 Oct; 60(1):23-7. PubMed ID: 2053326
    [Abstract] [Full Text] [Related]

  • 32. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
    Huang T, Sun J, Liu J, Liu QF, Men FY.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
    [Abstract] [Full Text] [Related]

  • 33. Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.
    Cunard R, Marquez II, Ball ED, Nelson CL, Corringham S, Clopton P, Sanchez AP, Lane T, Ward DM.
    Transfusion; 2014 Jul; 54(7):1857-63. PubMed ID: 24372185
    [Abstract] [Full Text] [Related]

  • 34. Pre-transplant donor-type red cell transfusion is a safe and effective strategy to reduce isohemagglutinin titers and prevent donor marrow infusion reactions in major ABO-mismatched transplants.
    Mehta P, Ramprakash S, Raghuram CP, Trivedi D, Dhanya R, Agarwal RK, Faulkner L.
    Ann Hematol; 2021 Aug; 100(8):2071-2078. PubMed ID: 34148110
    [Abstract] [Full Text] [Related]

  • 35. Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients.
    Vannucchi AM, Bosi A, Grossi A, Guidi S, Saccardi R, Lombardini L, Rossi-Ferrini P.
    Leukemia; 1992 Mar; 6(3):215-9. PubMed ID: 1564959
    [Abstract] [Full Text] [Related]

  • 36. Is the ABO incompatibility a risk factor in bone marrow transplantation?
    Rozman P, Kosir A, Bohinjec M.
    Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
    [Abstract] [Full Text] [Related]

  • 37. A preliminary report on ABO incompatible bone marrow transplant.
    Tan P, Ong YW, Tien SL, Loh TF, Lim ST.
    Ann Acad Med Singap; 1991 Jul; 20(4):421-8. PubMed ID: 1799251
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Successful treatment of prolonged anemia after major ABO incompatible bone marrow transplantation for a case of myelodysplastic syndrome with recombinant erythropoietin].
    Koda K, Hayashi S, Ikeda K, Morita K, Tsuji Y, Takimoto R, Fujisaki Y, Nakazawa O.
    Rinsho Ketsueki; 1992 Jul; 33(7):991-3. PubMed ID: 1507422
    [Abstract] [Full Text] [Related]

  • 40. Transfusion-related problems following major ABO-incompatible bone marrow transplantation.
    Tasaki T, Satoh S, Gotoh K, Fujii K, Sasaki S, Takadate J, Tachibana M, Ono Y, Ishida Y.
    Transfus Apher Sci; 2003 Apr; 28(2):155-61. PubMed ID: 12679120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.